scispace - formally typeset
C

Chengsong Yue

Researcher at Third Military Medical University

Publications -  19
Citations -  244

Chengsong Yue is an academic researcher from Third Military Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 66 citations.

Papers
More filters
Journal ArticleDOI

Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry

TL;DR: Among patients with acute BAO, EVT administered within 24 hours of estimated occlusion time is associated with better functional outcomes and reduced mortality, and this nonrandomized cohort study was a nationwide prospective registry of consecutive patients presenting with an acute, symptomatic, radiologically confirmed BAO to 47 comprehensive stroke centers in China.
Journal ArticleDOI

Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial.

TL;DR: Among patients with large vessel occlusion acute ischemic stroke undergoing endovascular thrombectomy, treatment with intravenous tirofiban, compared with placebo, before endov vascular therapy resulted in no significant difference in disability severity at 90 days.
Journal ArticleDOI

Efficacy and safety of 3‐n‐butylphthalide combined with endovascular treatment in acute ischemic stroke due to large vessel occlusion

TL;DR: Among patients with AIS due to LVO, NBP combined with EVT is associated with better functional outcomes and reduced mortality risk without increasing the risk of sICH.
Journal ArticleDOI

Abstract TP143: Endovascular Treatment With Versus Without Tirofiban For Stroke Patients With Large Vessel Occlusion: The Multicenter, Randomized, Placebo-controlled, Double-blind RESCUE BT Clinical Trial

TL;DR: This trial aims to assess whether additional intravenous tirofiban therapy can improve the clinical outcomes of stroke patients with large vessel occlusion who undergo endovascular treatment within 24 hours of symptom onset.
Journal ArticleDOI

High neutrophil counts before endovascular treatment for acute basilar artery occlusion predict worse outcomes

TL;DR: Higher neutrophil counts predicted worse clinical outcomes 90 days after EVT, which supports the deleterious role of inflammation in patients with acute BAO despite EVT or successful recanalization.